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LKB1 is an evolutionary conserved kinase implicated in a wide range of cellular functions
including inhibition of cell proliferation, regulation of cell polarity and metabolism. When
Lkb1 is inactivated in the liver, glucose homeostasis is perturbed, cellular polarity is affected
and cholestasis develops. Cholestasis occurs as a result from deficient bile duct develop-
ment, yet how LKB1 impacts on biliary morphogenesis is unknown.
Methodology/Principal Findings
We characterized the phenotype of mice in which deletion of the Lkb1 gene has been spe-
cifically targeted to the hepatoblasts. Our results confirmed that lack of LKB1 in the liver
results in bile duct paucity leading to cholestasis. Immunostaining analysis at a prenatal
stage showed that LKB1 is not required for differentiation of hepatoblasts to cholangiocyte
precursors but promotes maturation of the primitive ductal structures to mature bile ducts.
This phenotype is similar to that obtained upon inactivation of Notch signaling in the liver.
We tested the hypothesis of a functional overlap between the LKB1 and Notch pathways by
gene expression profiling of livers deficient in Lkb1 or in the Notch mediator RbpJκ and iden-
tified a mutual cross-talk between LKB1 and Notch signaling. In vitro experiments confirmed
that Notch activity was deficient upon LKB1 loss.
Conclusion
LKB1 and Notch share a common genetic program in the liver, and regulate bile duct
morphogenesis.
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Introduction
The liver is a vital organ with many functions, one of which is bile production for lipid adsorption
[1]. Bile ducts lined by cholangiocytes carry bile produced by the hepatocytes to the intestinal
tract. During liver development, hepatoblasts differentiate into hepatocyte and cholangiocyte pre-
cursors which progressively mature to adult hepatocytes organized as cords and to cholangiocytes
organized as ducts. Cholangiocyte precursors initially surround the portal vein mesenchyme, and
form a ductal plate. The latter subsequently undergoes morphogenesis and remodelling to gener-
ate the bile ducts [2–4]. Defects in bile duct formation can impair bile duct flow eventually leading
to cholestasis.
Human genetic diseases and mutant mouse models have illustrated the importance of
Notch signaling in the development of bile ducts [5]. Alagille syndrome is an inherited disorder
characterized by bile duct paucity and variable degree of cholestasis [6]. Nearly 80% of patients
have mutations in JAGGED1 which encodes for a Notch receptor ligand; less frequently the
gene encoding for the Notch receptor NOTCH2 is mutated [7–9]. Upon ligand binding the
Notch receptor undergoes sequential proteolysis releasing the intracellular domain (NICD)
that translocates to the nucleus and associates with RbpJκ (Recombination signal binding pro-
tein immunoglobulin J kappa) to convert the RbpJκ corepressor complex into a coactivator
complex that stimulates gene transcription [5]. Mouse studies showed that Notch signaling
controls differentiation of bipotential hepatoblasts towards cholangiocytes as well as bile duct
morphogenesis [10–17].
LKB1 is a tumor suppressor encoded by the STK11 gene. It is an evolutionary conserved ser-
ine/threonine protein kinase implicated in a wide range of cellular functions including inhibi-
tion of cellular proliferation, regulation of cellular polarity and metabolism [18–20]. It is a
multi-task kinase that acts upstream of AMPK (AMP-activated protein kinase) and 12 AMPK-
related kinases [21]. LKB1 is a crucial regulator of apical epithelial cell polarity [19], and is able
to polarize intestinal epithelial cells [19,22,23]. However, this effect of LKB1 may be cell-type
specific, as deletion of LKB1 does not alter polarity of lung epithelial and pancreatic cells [24].
In the adult liver, LKB1 controls glucose and lipid metabolism [20,25,26]. In vitro studies
showed that LKB1 is required for hepatocyte polarization and establishment of the canalicular
network [27]. Bile duct paucity was observed in mice bearing a deletion of LKB1 in the liver
[28]. However, a developmental cause for the biliary defect was not investigated.
Here, we characterized the phenotype of mice in which the LKB1 gene has been specifically
deleted in the hepatoblasts. Mutant mice were strongly cholestatic and lacked bile ducts. Stud-
ies at the prenatal stage showed that LKB1 is not required for differentiation of cholangiocyte
progenitors and for ductal plate formation, but is required for bile duct morphogenesis by pro-
moting the maturation of the primitive ductal structures. At the molecular level, we showed
that LKB1 and Notch share a common genetic program in the liver, identifying a cross-talk
between LKB1 and Notch that likely regulates biliary morphogenesis.
Materials and Methods
Animals
Mice carrying two floxed alleles on the exons III to VI of the Lkb1 gene (Stk11lox/lox) [29] were
interbred with AlfP-Cre in which Cre is under the control of Albumin regulatory elements and α-
feto-protein enhancer [30] to generate mice with LKB1 deletion in the hepatoblasts (LKB1livemb).
Inactivation of the Notch pathway was carried out by crossing AlfP-Cre animals with mice carry-
ing floxed allele of RbpJκ [31], an essential co-factor of NICD. All animal procedures were carried
out according to French legal regulations and approved by an ethical committee, “Comité
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National de Réflexion Ethique sur l’Expérimenation Animale” under the registered number:
CEEA34.CP.077.12. All mice were kept in well-controlled animal housing facilities.
RNA extraction and RT-PCR
Total RNA was extracted from mouse tissues and cell lines with Trizol Reagent (Life technolo-
gies) according to manufacturer’s protocol. Reverse transcription was performed from 1 μg of
total RNA using Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics) and ran-
dom hexamer as primers. Quantitative PCR reactions were run using the Light Cycler 480 Sybr
Green I Master kit (Roche) and specific primers (Eurogentec) on a Light Cycler 480 thermocy-
cler (Roche). Values were normalized with 18S ribosomal RNA. Primer sequences are indicated
in S1 Table.
Immunoblot analysis
Total protein extracts from mouse liver were obtained from 100–200 mg of frozen tissue that
was bead-mill homogeneized in lysis buffer (50 mM Tris-HCl pH 7.4, 150 mMNaCl, 1 mM
EGTA, 1 mMDTT, 0.1 mM AEBSF, 1% Triton X-100), supplemented with a mixture of prote-
ase and phosphatase inhibitors (Roche) in a 10μl/μg ratio using a TissueLyser disruption sys-
tem (Qiagen, Hilder, Germany). Samples were centrifuged at 13.000 g for 10 min at 4°C and
supernatant was collected and kept at -80°C until analysis. Proteins were resolved by SDS–
PAGE, transferred to nitrocellulose and blocked with 5% BSA or 5% milk. Blots were incubated
with specific primary antibodies overnight at 4°C, washed, incubated with the corresponding
horseradish peroxidase-conjugated secondary antibodies (Cell Signaling) and developed by
enhanced chemiluminescence (Thermo Fisher Scientific, Waltham, MA). Images were
recorded using a super CCD camera of 3.2 megapixels driven by the LAS 4000 mini device (GE
Healthcare). LKB1 antibody (clone D60C5), AMPK and anti-phospho-AMPKαT172 were
from Cell Signaling Technologies. β-actin antibody was from Sigma Aldrich.
Blood biochemistry
Bilirubin levels were measured from plasma using the Bilirubin SF kits from Diasys according
to the manufacturer instructions. ALAT levels were measured from plasma using the ALATSF
kit from Diasys and according to the manufacturer instructions
Immunohistochemistry and Immunofluorescence
Mouse liver were minced in 3mm-thick sections and fixed in 10% formalin for 12 hours and
embedded in paraffin. For morphological analysis, dewaxed 2μm sections were stained with
hemalun and eosin.
CK19 and CD10 immunostaining procedures were performed on 5μm thick dewaxed tissue
section, boiled in pH6 citrate buffer for 40 minutes and incubated for 1h at room temperature
with primary antibody. After incubation with biotinylated secondary antibody, an avidin-bio-
tin amplification step was performed (Jackson laboratories) followed by a diaminobenzidine-
based revelation (Jackson laboratories) and counterstaining in hemalun. Anti-CD10 immuno-
histochemistry was performed using the MOM kit (Vector Laboratories). Anti-CK19 was a gift
from Sylvie Germain and anti-CD10 was from Tebu-Novocastra. Immunofluorescence stain-
ing for aPKCz was done on frozen sections. Antibody anti- aPKCz was from Santa-Cruz.
For immunostaining of developing bile ducts, embryos were fixed at 4°C for 4h in 4% para-
formaldehyde in PBS, washed overnight in PBS and embedded in paraffin. Tissue sections
were retrieved by boiling for 10 min in pH6 citrate buffer, permeabilized for 15 minutes with
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0.3% Triton X-100-PBS, and blocked in 3% milk/10% BSA/0.3% Triton X-100 in PBS for 45
minutes at room temperature. Primary antibodies were purchased from Santa-Cruz (HNF4,
HNF6 and HNF1β), BD biosciences (E-cadherin), Chemicon (Sox9), R&D systems (osteopon-
tin). Anti-HES1 was provided by B. Stanger, and anti-Notch2 NICD developed by S. Artava-
nis-Tsakonas was obtained from the Developmental Study Hybridoma Bank, created by the
NICHD of the NIH and maintained at the University of Iowa, Department of Biology, Iowa
City, IA 52242. Incubation of primary antibodies was performed in 3% milk/10% BSA/0.3%
Triton X-100 in PBS for 1 hour at 37°C. Washes were done with 0.1% Triton X-100 in PBS
three times for 5 minutes each. Secondary antibodies Alexa Fluor1 conjugated were purchased
from LifeTechnologies. Washes were repeated with 0.1% Triton X-100-PBS three times for 5
minutes each and slides were mounted in Dako1 fluorescent mounting medium (Dako). Fluo-
rescence was immediately observed with a Zeiss Axiovert 200 inverted fluorescence micro-
scope. All the pictures were taken using a Coolpix 995 digital camera (Nikon).
Microarray analysis, statistical analysis and data mining
Three hundred ng of total RNA were reverse transcribed following the Genechip Whole tran-
script (WT) Sense Target labelling assay kit (Affymetrix). The resulting cDNA was used for in
vitro transcription with T7 RNA polymerase. After purification, 10 μg of cRNA was used for
reverse transcription with random primers. The cDNA obtained was purified and fragmented.
After control of fragmentation using 2100 Bioanalyzer, cDNA was end-labelled with biotin
using Terminal Transferase (WT terminal labelling kit, Affymetrix). cDNA was then hybrid-
ized to GeneChip1Mouse Gene (Affymetrix) at 45°C for 17 hours. Chips were washed on
the fluidic station FS450 following specific protocols (Affymetrix) and scanned using the
GCS3000 7G. The image was analyzed with Expression Console software (Affymetrix) to
obtain raw data (cel files) and metrics for Quality Controls. Data have been deposited in GEO
database (GSE75564).
Microarray data were analyzed using R-based BRB-Array Tools as previously described
[32]. Briefly, differentially expressed genes were identified by a univariate two-sample t-test
with a random variance model. Individual genes were selected on the basis of both statistical
significance (p<0.001) and fold change (FC) difference between the compared groups
(FC>1.5). False discovery rate (FDR)/q-value has been calculated as previously described [33].
Ingenuity pathway analysis (IPA) software (Mountain View, CA, USA) was used to examine
the functional association between differentially expressed genes and to generate the most sig-
nificantly altered molecular functions that were identified using the scoring system provided
by IPA. Gene set enrichment analysis (GSEA) was performed by using the Java-tool developed
at the Broad Institute (Cambridge, MA, USA).
Cell Culture and Transfections
The human cholangiocarcinoma Mz-ChA-1 [34], a gift of Laura Fouassier (Inserm UPMC
UMRS-938, Paris France) and the human hepatocellular carcinoma cell line HUH7 were culti-
vated in Dubelcco’s modified Eagle’s medium (DMEM, Life Technologies) supplemented with
10% fetal bovine serum and 100U/ml penicillin/streptomycin at 37°C under 5% CO2. For
transfection, 0.5x106 cells were seeded in each well of a 6-well plate. The Notch RBPJ reporter
plasmid contains four copies of the RbpJκ-binding element cloned upstream of a SV40 pro-
moter-driven luciferase reporter construct and was a kindly gift from Evelyne Lauret (Institut
Cochin, Paris, France). The expression vector encoding Notch 1 intracellular domain (NICD)
was a gift from Evelyne Lauret (Institut Cochin, Paris, France). The human LKB1 siRNA pool
is a SMART selection designed from Thermo Fischer Scientific, Dharmacon Product. Human
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scrambled siRNA (ON-TARGETplus-Non-Targeting pool) was from Dharmacon. RSV-Re-
nilla was used to normalize transfection efficiency. Cells were either co-transfected with
increasing doses of NICD, 250 ng of RBPJ reporter and 10 ng of RSV-Renilla, or co-transfected
with 50 or 100 pmol of siRNA, 250 ng of RBPJ reporter and 10 ng of RSV-Renilla. The transfec-
tion was done using the Lipofectamine1 RNAiMAX protocol according to the manufacturer’s
protocol (Life Technologies). Forty-eight hours after transfection, Luciferase activity was mea-
sured with the Dual-Luciferase reporter assay system (Promega, Madison, WI). Results were
expressed as firefly luciferase activity normalized to Renilla luciferase activity of the same sam-
ple. Each point was done in triplicate.
Results
Liver cholestasis is induced in mice with LKB1 deletion in hepatoblasts
We specifically deleted Lkb1 in the liver using mice with floxed Lkb1lox/lox alleles [29] and
transgenic Alfp-Cre [30]. In the latter, Cre recombinase is active in hepatoblasts starting at
E10.5. The mutant animals were named LKBKOLivemb. After confirming that Lkb1 was effi-
ciently deleted in the liver (Fig 1A), we studied the phenotype of these mice. LKBKOLivemb
mice were born at the expected Mendelian frequency, but showed severe growth retardation
beginning at post-natal day 12 and leading to death between day 25 and day 30 (Fig 1B and
1C). The severity of the phenotype of LKBKOLivemb mice differed from that observed in the
work by Woods et al. [28]. In the latter, defective growth was detected at an earlier stage (post-
natal day 4) while we observed growth defect at the suckling/weaning transition. Furthermore,
Woods et al. detected cytolysis as assessed by elevated transaminase levels; in contrast, we
found normal serum ALAT levels in LKBKOLivemb mice. The difference in the liver phenotype
between the two studies is likely explained by the genetic difference of the two models: Woods’
study was done using an hypomorphic floxed Lkb1 model harbouring strong reduction in
LKB1 protein expression in Cre-negative mice [35] while no such decrease was observed in our
Cre-negative mice (Fig 1A).
The LKBKOLivemb mice were strongly cholestatic as shown by the yellow color of the serum
and elevated serum bilirubin levels (Fig 1D). The high level of conjugated bilirubin and the
normal ALAT levels indicated that cholestasis resulted from a biliary obstruction (Fig 1D). Bile
canaliculi are channels formed by the juxtaposition of apical pole of adjacent hepatocytes.
Using the apical marker aPKCz to detect the bile canaliculi, we found, as expected, an elon-
gated and bar-shaped bile canalicular network in control animals. In contrast, the aPKCz stain-
ing was tortuous and dilated in LKBKOLivemb mice (Fig 2A). Mutant mice failed to express the
hepatocyte canalicular membrane, CD10 [36], reinforcing that bile canalicular network was
defective (Fig 2A). Similar results were observed in the Wood’s study [28]. We then examined
the intrahepatic bile ducts in LKBKOLivemb mice. In control livers at postnatal day 15, one to
two CK19-positive bile ducts were located in each portal tract (Fig 2B). In contrast, mutant ani-
mals showed CK19-positive cells organized around the portal tract like embryonic ductal plate
structures, but failed to develop ducts (Fig 2B). Thus, LKBKOLivemb mice revealed defects in
hepatocytes with aberrant apical polarization leading to defective bile canaliculi, and defects in
bile duct formation that all were responsible for the cholestasis.
LKB1 promotes maturation of bile ducts during biliary morphogenesis
To determine how LKB1 deletion causes defective duct formation, we analyzed bile duct mor-
phogenesis at prenatal stages. During normal embryonic development, hepatic progenitor cells
adjacent to the portal vein form a structure composed of cholangiocyte precursors, called duc-
tal plate. Then, prior to birth, tubulogenesis occurs at discrete areas along the ductal plate,
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
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Fig 1. Phenotype of mice carrying Lkb1 deletion in the embryonic liver. (A) LKBKOlivemb mouse model results in efficient inactivation of Lkb1 protein
expression in the liver. Western blot analysis of Lkb1 and β-actin (loading control) of liver lysates from wild-type, control (LKB1fl,fl, Cre-) designedWT and
mutant (LKB1fl,fl, Cre+) mice designed KO (2-week old mice). (B) Gross appearance of a control (WT) and mutant (KO) LKBKOlivemb mice at postnatal day
28. (C)Weight curves from birth to post-natal day 30 in the LKBKOlivemb model. Mice genotypes were determined at postnatal day 5. N = 15 control and 8
mutant mice. Error bars: standard deviations.* P<0.01, ** P<0.05, *** P<0.001. Deletion of Lkb1 in the embryonic liver causes postnatal growth retardation
beginning at day 12. (D)Obstructive cholestasis in LKBKOlivemb mutant mice. Gross aspect of serum from a control (WT) and mutant (KO) LKBKOlivemb mice
at postnatal day 15. Blood levels of conjugated bilirubin and ALAT in LKBKOlivemb control (WT) and mutant (KO) mice at postnatal day 15. n = 6 control and 4
mutant mice. Error bars: standard deviations. Statistical significance was evaluated using a two-sample unpaired Student’s t-test between KO and mutant
animals. *** P<0.001.
doi:10.1371/journal.pone.0145400.g001
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Fig 2. Lkb1 is required for canaliculi formation and intrahepatic bile ducts morphogenesis. (A) Top
panel: representative images of 3-week old control and mutant LKBKOlivemb mice liver sections stained with
the apical marker aPKCζ. Note the elongated canalicular network and the tortuous dilated bile canaliculi in
control and mutant animal, respectively. Bottom panel: representative images of 3-week old control and
mutant LKBKOlivemb mice liver sections stained with the anti-CD10 antibody. Immunohistochemistry
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
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giving rise to asymmetrical ducts, called primitive ductal structures (PDS) lined by Sox9
+/HNF4- cholangiocytes and Sox9-/HNF4+ hepatoblast-like cells. Around embryonic day
E17-E18, these structures mature to bile ducts entirely and symmetrically lined by Sox9
+/HNF4- cholangiocytes [3,37]. Cholangiocyte precursors of the ductal plate not involved in
duct formation give rise to periportal hepatocytes and to cells of the Hering’s canal [38].
In control animals, at E18.5, developing ducts were symmetrical and completely lined with
Sox9+/HNF4- cells. In contrast, at that stage developing ducts of LKBKOLivemb mice were still
in an asymmetrical configuration typical of PDS: the duct lumina were surrounded on the por-
tal side by Sox9+/HNF4- cholangiocytes and on the opposite, i.e. parenchymal side, by Sox9-/
HNF4+ hepatoblasts (Fig 3A). We then tested the expression of key transcription factors of
bile duct morphogenesis, namely HNF1β and HNF6 [39–41]. These factors were normally
expressed on the parenchymal and portal sides of developing ducts, in wild-type livers and
only in the portal side of the ducts of the LKBKOLivemb livers (Fig 3B). As well, the nuclear loca-
tion of the Notch intracellular domain (NICD) and the expression of the Notch target gene
Hes1 were asymmetrical in developing ducts of mutant embryos, in contrast to control animals
revealing a symmetrical expression (Fig 3C). These data demonstrated that in the absence of
LKB1, duct morphogenesis is arrested at the PDS stage and that Notch signaling is not func-
tional on the parenchymal side of the developing ducts in the absence of LKB1. In mutant
animals, the PDS do not mature to bile ducts and, together with the other cholangiocyte pre-
cursors not involved in duct formation, remain at an embryonic stage, explaining the ductal-
plate-like structure observed in adult animals.
Cross-talk between LKB1 and Notch pathways in liver
The biliary phenotype of LKBKOLivemb mice is reminiscent of that observed in mice with inac-
tivation of Hes1, Jagged 1, or RbpJκ [11,15,17]: all these mice develop a ductal plate which fails
to generate ducts. This suggested that LKB1 cross-talks with the Notch pathway in the liver. To
check this hypothesis we analyzed Rbpjlox/lox;Alfp-Cre (RBPJKOlivemb) mice which have a liver-
specific inactivation of RbpJκ. Control, RBPJKOlivemb and LKBKOLivemb mice were sacrificed 5
days after birth and the liver transcriptomes were analyzed using microarrays. 253 non redun-
dant genes were differentially expressed between LKBKOLivemb and control mice (see S2
Table); 237 genes were differentially expressed between RBPJKOlivemb and control mice (see S3
Table). Interestingly, numerous genes (54 out of 55 genes, i.e. 20–25% of each list, see S4 Table)
were similarly deregulated in the liver of LKBKOLivemb and RBPJKOlivemb mice (Fig 4A).
Accordingly, Gene Set Enrichement Analysis (GSEA) revealed that the LKBKOlivemb gene sig-
nature was significantly enriched in the gene expression profile of RBPJKOlivemb livers, and
vice versa (Fig 4B). Analysis of functional gene networks using Ingenuity Pathway Analysis
highlighted the metabolic pathways as the main deregulated pathways in both the LKB1 and
Notch gene datasets (Fig 4C).
To confirm in vitro, the cross-talk between LKB1 and Notch signaling pathways the cholan-
giocarcinoma cell line Mz-ChA-I was used. A Notch-responsive luciferase reporter system
containing RbpJκ binding sites [42] allowed us to monitor the level of Notch activation.
evidences a delicate canalicular network at the apical pole of the hepatocytes of control animal. In KOmice,
the staining was lost. Top: low magnification, middle and bottom: high magnification. (B) Top panel:
Hematoxylin-eosin (H&E) stained sections of 3-week old control and mutant LKBKOlivemb mouse liver. Middle
and bottom panels: Cytokeratin 19 (CK19)-stained sections of 3-week old control and mutant LKBKOlivemb
mouse livers. Note the well-formed and mature bile ducts in the control mouse and the numerous ductal
plate-like structures around the portal tract in mutant mice. Top two panels: high magnification, bottom panel:
scanning magnification.
doi:10.1371/journal.pone.0145400.g002
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Fig 3. Lkb1 controls the maturation of bile duct during bile duct tubulogenesis. (A)
Immunofluorescence for Sox9, HNF4 and E-cadherin demonstrate that Lkb1 is required for the transition
from an asymmetric primitive duct to a symmetric and mature bile duct in the developing liver. LKBKOlivemb
(KO) embryos were sampled at E18.5 and liver sections were stained for the hepatoblast marker HNF4, and
for the cholangiocyte markers Sox9. Note the symmetrical localization of Sox9 around the bile duct in control
mice (Control) whereas Sox9 was only expressed in the portal layer of the asymmetric bile ducts in mutant
embryos. High E-cadherin levels mark mature cholangiocytes. (B) Representative immunofluorescence for
HNF1β and HNF6 in control and LKBKOlivemb livers in top and bottom panels respectively. Medium-high
magnifications. (C) Notch-ICD and Hes-1 expression are restricted to the portal layer of asymmetrical bile
duct in LKBKOlivemb mutant mice whereas Notch activation was evidenced in both layers of the biliary tubules
in control animals. Mediummagnification.
doi:10.1371/journal.pone.0145400.g003
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Fig 4. Inactivation of Lkb1 and Notch in the liver share a common gene signature. (A) RBPJKOlivemb and LKBKOlivemb models share a common gene
expression signature. Upper part: Venn diagram of genes differentially expressed (p<0.001, fold change>1.5) between mutant and control mice in the
LKBKOlivemb and RBPJKOlivemb (5-days old) models. Fifty-five genes were found to be deregulated in the two models. Lower part: Supervised hierarchical
clustering analysis demonstrates that 54 (out of 55) common genes are similarly deregulated in the two models. (B) Gene Set Enrichment Analysis (GSEA)
demonstrates that the Lkb1 and Notch pathways share a common transcriptional program. RBPJKOlivemb (upper part) and LKBKOlivemb (lower part) gene
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
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Transfection of NICD induced a dose-dependent increase in luciferase activity, as expected
(Fig 5A). More interestingly, we observed a decrease in luciferase activity after LKB1 inactiva-
tion by siRNA and not in cells transfected with a scrambled siRNA (Fig 5B and 5C). This result
confirmed that Notch activation is deficient in the absence of LKB1. Similar results were
obtained using the hepatocellular carcinoma cell line HUH7 (Fig 5D), indicating that the dialog
between LKB1 and Notch signaling extends beyond bile duct cells. We then search for an epi-
static relation between the LKB1 and Notch signaling, and characterized the activation status
of the Notch pathway in LKB1 mutant animals, and reciprocally, the level of LKB1 expression
in Notch mutant livers. Expression of several Notch pathway targets (Hes1,Hey1,Heyl and
Nrarp) was downregulated in the liver of LKBKOLivemb mutant mice corroborating the results
we obtained using the Mz-ChA-I cell line (Fig 5E). Reciprocally, Notch inactivation was associ-
ated with down-regulation of LKB1 protein and its downstream kinase, AMPK, as revealed by
the level of phosphorylated AMPK (Fig 5F). These results showed a mutual cross-regulation
between the LKB1 and Notch pathways without evidence that one is epistatic to the other.
Discussion
In the present work we identify a new role of LKB1 in bile duct development. In the absence
of LKB1 differentiation of hepatoblasts to cholangiocyte precusors proceeds normally; the
precursors organize as a ductal plate and generate PDS, but the latter fail to mature to ducts. A
similar maturation defect has been observed in the absence of HNF1β [41]. We showed that
Notch pathway activation was deficient in the absence of LKB1, by in vivo and in vitro
approaches. Since Notch pathway deficiencies are associated with a biliary phenotype similar
to that of LKBKOLivemb mice, we suggest that LKB1 controls Notch signaling during bile duct
development.
The failure of PDS to mature and generate ducts may reflect polarity defects in
LKBKOLivemb mice. When PDS mature to ducts, the cells on the parenchymal side become
progressively more polarized and expressed higher level of E-cadherin [37]. A co-localization
between LKB1 and E-cadherin has been described at the adherens junction and E-cadherin is
required for the recruitment of active LKB1 complex to adherens junction in polarized epithe-
lial cells [43]. Thus, a polarity clue mediated by LKB1 may be the signal that allows the transi-
tion of PDS to a symmetric bile duct. In addition, deficient apical polarization of hepatocytes
was likely to explain the abnormal development of bile canaliculi in mutant mice. Therefore,
polarization of hepatocytes and cholangiocytes may constitute a key function of LKB1 during
liver development.
Hepatocytes have a marked anatomical polarity that plays an essential role for biliary secre-
tion. Several bile acid transporters are localized at the canalicular apical pole. In vitro studies
showed that formation and maintenance of bile canalicular network of the hepatocytes is regu-
lated by the LKB1 and AMPK pathways [27]. Accordingly, we observed loss of the bile canalic-
ular network in LKBKOLivemb mice. Thus alterations in both hepatocytes and cholangiocytes
signatures were used for GSEA using the gene expression profiles of LKBKOlivemb (upper part) and RBPJKOlivemb (lower part) mice and their respective
control (WT) counterparts. Up- and down-regulated genes in the RBPJKOlivemb signature were found to be specifically enriched in the gene expression
profiles of LKBKOlivemb and control (WT) mice, respectively. Similarly, up- and down-regulated genes in the LKBKOlivemb signature were found to be
specifically enriched in the gene expression profiles of RBPJKOlivemb and control (WT) mice, respectively. All gene sets were significantly enriched at
nominal p-value<1%. (C) Most significantly altered functions revealed by Ingenuity Pathway Analysis (IPA). A dataset containing gene identifiers and
corresponding values were uploaded to the Ingeniuty Pathway analysis software (IPA). The transcripts differentially expressed between KO andWT that met
the cutoff criteria (FC > 1.5, p< 0.001) were considered for the analysis. Bars represent the logarithmic value of the significance level, the dashed line
corresponds to the threshold of 0.05.
doi:10.1371/journal.pone.0145400.g004
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Fig 5. Cross-talk between LKB1 and Notch signaling. (A) The RBP-J luciferase reporter was transfected into Mz-Cha-1 cells either alone (0) or with
increasing dose of NICD vector (ng) as indicated. (B) Silencing by 50 pmol -100 pmol of LKB1 siRNA (LKB) and scrambled siRNA (SC). LKB1 protein was
revealed by western blot. β-actin was used as loading control. (C-D) LKB1 silencing led to decrease Notch activity. Luciferase activity was measured in the
absence of siRNA (1), in the presence of either 50 pmol of LKB1 siRNA or scrambled siRNA (2) and the presence of 100 pmol of either LKB1 siRNA or
scrambled siRNA (3). Transfections were done in Mz-ChA-1 cells (C) or in HUH7 cells (D). * P< 0.05. ** P<0.01. (E) LKB1 is required for full activation of
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explain the cholestatic phenotype of mutant mice which do not have mature bile ducts and
present defective bile canalicular network.
At the molecular level, our in vivo and in vitro analyses showed that LKB1 loss led to a
decrease in Notch activity, but the mechanism by which LKB1 controls Notch activation
remains to be investigated. Interestingly, our results indicated that Notch-deficient mice dis-
played a decrease in the LKB1 activity highlighting a cross-regulation of LKB1 and Notch sig-
naling. The liver is not the only organ in which LKB1 and Notch cross-talks. A connection
between the LKB1 and Notch pathway has been recently described in the intestinal epithelium.
Deletion of LKB1 in the epithelial cells of the intestine is associated with a modification of the
differentiation of the intestinal lineage towards an increase in goblet and Paneth cell lineage
known to be negatively controlled by Notch signaling [44]. Similar to our results, a decrease in
Notch activation was evidenced in intestine of mice bearing specific deletion of LKB1 [45].
Therefore, our work and that of others point toward a combinatorial role of LKB1 and Notch
in cell fate decision and organ morphogenesis.
Our gene expression profiling results further highlight that the Notch pathway has roles that
extend beyond development and that it impacts on organ homeostasis [5]. Recent data show
that Notch participates in liver glucose and lipid homeostasis [46,47]. Accordingly numerous
genes linked to lipid metabolism were present in the shared LKB1-Notch dataset (see Fig 4A).
Conclusion
Liver-specific deletion of LKB1 in transgenic mice identified LKB1 as an actor of bile duct mat-
uration during biliary morphogenesis. Our data suggest that a mutual cross-talk between LKB1
and the Notch pathway is involved in bile duct morphogenesis.
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